-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Immunocore Holdings plc quarterly/annual Cost of Revenue history and growth rate from 2021 to Q3 2025.
- Immunocore Holdings plc Cost of Revenue for the quarter ending September 30, 2025 was $513K, a 14.5% increase year-over-year.
- Immunocore Holdings plc Cost of Revenue for the twelve months ending September 30, 2025 was $2.71M, a 4.39% increase year-over-year.
- Immunocore Holdings plc annual Cost of Revenue for 2024 was $2.73M, a 163% increase from 2023.
- Immunocore Holdings plc annual Cost of Revenue for 2023 was $1.04M, a 4.78% decline from 2022.
- Immunocore Holdings plc annual Cost of Revenue for 2022 was $1.09M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)